NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
8.21
-0.07 (-0.85%)
At close: Aug 14, 2026, 4:00 PM EDT
8.03
-0.18 (-2.19%)
After-hours: Aug 14, 2026, 7:34 PM EDT

NextCure Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-38.82-57.62-57.21-67.64-75.91-70.77
Net Income
-42.75-55.84-55.65-62.72-74.73-69.39
Earnings Per Share
-9.94-19.65-23.88-27.04-32.32-30.15
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
29.7441.8268.62108.3159.91219.59
Total Debt
4.915.155.956.617.12-
Net Cash (Debt)
24.8336.6762.67101.69152.79219.59
Net Cash Growth
-16.45%-41.50%-38.37%-33.44%-30.42%-21.57%
Net Cash Per Share
5.7712.9026.8943.8466.0895.42

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--49.61-40.81-52.97-53.89-57.28
Capital Expenditures
---0.47-0.82-2.12-2.36
Free Cash Flow
--49.61-41.28-53.79-56-59.64
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------